Lily Kim is an independent consultant in the San Francisco Bay Area who advises funders on new biotechnology landscapes, performs due diligence, and has been involved in venture creation. Earlier she was part of the business development team driving early stage technology commercialization at the Wyss Institute for Biologically Inspired Engineering at Harvard University, where she worked with a variety of technologies including DNA nanotechnology, synthetic biology, diagnostics, medical devices and drug delivery. In Boston Lily also founded FluidicMEMS, a resource for the microfluidics commercialization community. She has served on the MIT Enterprise Forum Innovation Series Committee, was selected as one of Mass High Tech’s “Women to Watch” in 2013, and is on the Board of Directors of the Hertz Foundation.
Lily has a Ph.D. in biomedical engineering from the Harvard-MIT Division of Health Sciences and Technology and an M.Eng. and S.B. in electrical engineering from MIT, and was awarded a Hertz Fellowship. She wants to help accelerate and improve the process of early stage life sciences commercialization.